PMC:7600245 / 45339-45541 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T665","span":{"begin":90,"end":103},"obj":"Chemical"}],"attributes":[{"id":"A665","pred":"chebi_id","subj":"T665","obj":"http://purl.obolibrary.org/obo/CHEBI_26333"}],"text":"sible inhibition of cyclooxygenase-1 and 2 enzymes, which leads to decreased formation of prostaglandin precursors [142]. Orally administered indomethacin is being evaluated in combination with hydroxyc"}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T76","span":{"begin":77,"end":86},"obj":"http://purl.obolibrary.org/obo/GO_0009058"}],"text":"sible inhibition of cyclooxygenase-1 and 2 enzymes, which leads to decreased formation of prostaglandin precursors [142]. Orally administered indomethacin is being evaluated in combination with hydroxyc"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1372","span":{"begin":20,"end":42},"obj":"Gene"},{"id":"1375","span":{"begin":90,"end":103},"obj":"Chemical"},{"id":"1376","span":{"begin":142,"end":154},"obj":"Chemical"}],"attributes":[{"id":"A1372","pred":"tao:has_database_id","subj":"1372","obj":"Gene:5742"},{"id":"A1375","pred":"tao:has_database_id","subj":"1375","obj":"MESH:D011453"},{"id":"A1376","pred":"tao:has_database_id","subj":"1376","obj":"MESH:D007213"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"sible inhibition of cyclooxygenase-1 and 2 enzymes, which leads to decreased formation of prostaglandin precursors [142]. Orally administered indomethacin is being evaluated in combination with hydroxyc"}